GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innoveren Scientific Inc (OTCPK:IVRN) » Definitions » Shiller PE Ratio

Innoveren Scientific (Innoveren Scientific) Shiller PE Ratio : (As of May. 29, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Innoveren Scientific Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Innoveren Scientific Shiller PE Ratio Historical Data

The historical data trend for Innoveren Scientific's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innoveren Scientific Shiller PE Ratio Chart

Innoveren Scientific Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Innoveren Scientific Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Innoveren Scientific's Shiller PE Ratio

For the Biotechnology subindustry, Innoveren Scientific's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innoveren Scientific's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innoveren Scientific's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Innoveren Scientific's Shiller PE Ratio falls into.



Innoveren Scientific Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Innoveren Scientific's E10 for the quarter that ended in Sep. 2023 is calculated as:

For example, Innoveren Scientific's adjusted earnings per share data for the three months ended in Sep. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-0.73/129.8595*129.8595
=-0.730

Current CPI (Sep. 2023) = 129.8595.

Innoveren Scientific Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201312 0.000 98.326 0.000
201403 -60.747 99.695 -79.127
201406 -76.331 100.560 -98.572
201409 -62.900 100.428 -81.334
201412 -120.240 99.070 -157.609
201503 -160.000 99.621 -208.565
201506 -190.000 100.684 -245.057
201509 -130.000 100.392 -168.159
201512 -130.000 99.792 -169.169
201603 -160.000 100.470 -206.802
201606 -730.000 101.688 -932.237
201609 -130.000 101.861 -165.733
201612 -190.000 101.863 -242.221
201703 -140.000 102.862 -176.745
201706 -70.000 103.349 -87.956
201709 -70.000 104.136 -87.292
201712 -80.000 104.011 -99.881
201803 -30.000 105.290 -37.001
201806 -10.000 106.317 -12.214
201809 -60.000 106.507 -73.156
201812 -50.000 105.998 -61.256
201903 -50.000 107.251 -60.540
201906 -60.000 108.070 -72.098
201909 -30.000 108.329 -35.962
201912 -210.000 108.420 -251.526
202003 -30.000 108.902 -35.773
202006 -60.000 108.767 -71.635
202009 10.000 109.815 11.825
202012 -10.000 109.897 -11.816
202103 -10.000 111.754 -11.620
202106 -14.900 114.631 -16.879
202109 -4.119 115.734 -4.622
202112 -2.930 117.630 -3.235
202203 -23.010 121.301 -24.633
202206 -11.970 125.017 -12.434
202209 -8.040 125.227 -8.337
202212 -0.990 125.222 -1.027
202303 -3.380 127.348 -3.447
202306 0.770 128.729 0.777
202309 -0.730 129.860 -0.730

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Innoveren Scientific  (OTCPK:IVRN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Innoveren Scientific Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Innoveren Scientific's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Innoveren Scientific (Innoveren Scientific) Business Description

Traded in Other Exchanges
N/A
Address
2202 N West Shore Boulevard, Suite 200, Tampa, FL, USA, 33607
Innoveren Scientific Inc Formerly H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.
Executives
Fwhc Holdings, Llc 10 percent owner 1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Hoa Capital Llc 10 percent owner 1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Farrior J Rex Iii 10 percent owner 1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Fwhc Bridge Friends, Llc 10 percent owner 1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Raymond Monteleone director 201 E KENNEDY BLVD, STE 700, TAMPA FL 33602
Jeremy Daniel officer: Chief Financial Officer 201 E KENNEDY AVE, STE 700, TAMPA FL 33602
Robert Smith Greif officer: President and C.E.O. 19 MAY STREET, NEEDHAM MA 02492
Cfrs Investments, Llc 10 percent owner 2903 W VILLA ROSA PARK, TAMPA FL 33611
Frederick J Lynch 10 percent owner C/O MASONITE INTERNATIONAL CORPORATION, 201 NORTH FRANKLIN ST., SUITE 300, TAMPA FL 33602
Fwhc Bridge, Llc 10 percent owner 334 EAST LAKE ROAD, SUITE 176, PALM HARBOT FL 34685
Todd R Wagner 10 percent owner 3385 OLD KEYSTONE ROAD, TARPON SPRINGS FL 34688
Michael Yurkowsky director 2380 OLD MILTON PARKWAY, ALPHARETTA GA 30009
William E Horne director, officer: Chief Executive Officer 201 EAST KENNEDY BLVD, SUITE 700, TAMPA FL 33602
Jon Mogford director 714 PLUM HOLLOW DRIVE, COLLEGE STATION TX 77845
John C Thomas director 8601 SIX FORKS ROAD, SUITE 160, RALEIGH NC 27615